Clinical trial
Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations
NCT02042326 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire, Amiens as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations
- Lead sponsor
- Centre Hospitalier Universitaire, Amiens
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- September 12, 2014
- Completion date
- September 30, 2027
- Enrollment
- 50 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.